Maple Biotech in
Pharmaceutical Market Overview
Regulatory Framework & Pharmacopoeia Standards
Excipients & Products Exported to
Key Pharmaceutical Excipients for
| Excipient / Brand | Primary Application | Pharmacopoeia Standard |
|---|
About Maple Biotech — India's WHO-GMP Excipient Manufacturer
Maple Biotech Pvt. Ltd. (est. 1982, Pune, India) is a WHO-GMP, ISO 9001:2015, and FSSC 22000 certified manufacturer and exporter of pharmaceutical excipients, food-grade ingredients, and specialty polymers. Our 60,000 sq.ft. state-of-the-art facility produces over 1,000 MT of excipients per month, including globally recognized brands: AMBICEL® Microcrystalline Cellulose (MCC 101, 102, 200, 301, 302), CEL-CA-DISSOL® Croscarmellose Sodium, CRODIS® Crospovidone, POVIMINE® Povidone K30/K90, MAPECTIN® Pectin (HM/LM), CARBOGENIX® Sodium CMC, and SAPCEL® Super Absorbent Polymers.
Our excipients meet all major pharmacopoeias — USP-NF, European Pharmacopoeia (EP), British Pharmacopoeia (BP), Japanese Pharmacopoeia (JP), Chinese Pharmacopoeia (ChP), and Indian Pharmacopoeia (IP) — making us the preferred single-source supplier for pharma companies operating across multiple regulated markets. Over 500 pharmaceutical, nutraceutical, and food companies across 75+ countries trust Maple Biotech for consistent quality, competitive USD pricing, and complete regulatory support.
For every export order we provide: Certificate of Analysis (CoA), GMP Certificate, Drug Master File (DMF) reference letters, TSE/BSE declaration, stability data, Halal & Kosher certificates, and country-specific regulatory compliance documentation. Our dedicated export team responds to all inquiries within 24 hours with competitive USD quotations.